Stacey Wade-James v. Genzyme Corporation

CourtDistrict Court, C.D. California
DecidedFebruary 7, 2025
Docket2:24-cv-01364
StatusUnknown

This text of Stacey Wade-James v. Genzyme Corporation (Stacey Wade-James v. Genzyme Corporation) is published on Counsel Stack Legal Research, covering District Court, C.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Stacey Wade-James v. Genzyme Corporation, (C.D. Cal. 2025).

Opinion

O 1

2 3 4 5 6 7

8 United States District Court 9 Central District of California

11 STACEY WADE-JAMES, Case № 2:24-cv-01364-ODW (SSCx)

12 Plaintiff, ORDER GRANTING MOTION TO 13 v. 14 G ENZYME CORPORATION, d/b/a DISMISS [25] SANOFI et al., 15

Defendants. 16

17 18 I. INTRODUCTION 19 Plaintiff Stacey Wade-James claims that her former employer, Defendant 20 Genzyme Corporation d/b/a Sanofi (“Sanofi”), unlawfully discriminated against her 21 based on her Christian faith when it failed to accommodate her request for exemption 22 from Sanofi’s COVID-19 vaccine mandate and terminated her employment. (First Am. 23 Compl. (“FAC”) ¶¶ 66–108, ECF No. 23.) Sanofi moves to dismiss three of 24 Wade-James’s causes of action pursuant to Federal Rule of Civil Procedure 25 (“Rule”) 12(b)(6). (Mot. Dismiss (“Motion” or “Mot.”), ECF No. 25.) For the reasons 26 below, the Court GRANTS Sanofi’s Motion.1 27

28 1 Having carefully considered the papers filed in connection with the Motion, the Court deemed the matter appropriate for decision without oral argument. Fed. R. Civ. P. 78; C.D. Cal. L.R. 7-15. 1 II. BACKGROUND2 2 From approximately June 2015 to October 2021, Sanofi employed Wade-James 3 to work as a Senior Cardiovascular Representative. (FAC ¶¶ 11, 44.) In August 2021, 4 Sanofi’s US Crisis Committee issued a written notice to employees announcing a new 5 policy requiring Wade-James and other similarly situated employees to become 6 vaccinated against COVID-19 by October 4, 2021. (Id. ¶ 16.) Wade-James submitted 7 a religious accommodation request to be exempted from the policy. (Id. ¶ 25.) In her 8 request, Wade-James informed Sanofi that she believed her body was a “temple of God” 9 and the COVID-19 vaccine was akin to “unclean food” and should not be consumed. 10 (Id. ¶ 26.) Sanofi’s Associate Director of Employee Relations interviewed Wade-James 11 about her religious accommodation request, asking Wade-James “intrusive questions, 12 such as whether [she] had ever had vaccinations as a child and as an adult.” (Id. ¶ 28.) 13 In response to requests to provide information or documentation indicating that the 14 COVID-19 vaccine was against Christian beliefs, Wade-James shared biblical 15 scriptures. (Id. ¶ 30.) Wade-James perceived that the Associate Director “appeared to 16 reject” Wade-James’s biblical scriptures, and understood that to mean that Sanofi was 17 “hostile to her religious beliefs.” (Id.) 18 Based on the information Wade-James provided, Sanofi denied Wade-James’s 19 accommodation request because it found that she “did not substantiate the existence of 20 a sincerely held religious belief that is in conflict with obtaining a Covid-19 vaccine.” 21 (Id. ¶ 36.) Sanofi reiterated that Wade-James was required to become vaccinated by 22 October 4, 2021, and that failure to do so would result in her termination effective 23 October 5, 2021. (Id. ¶ 38.) Wade-James appealed and, after further review, Sanofi 24 denied the appeal. (Id. ¶¶ 41–42.) In the appeal denial, Sanofi again notified 25 Wade-James that she was required to submit proof of vaccination by October 4, 2021, 26 as a condition of continued employment, and that failure to do so would result in 27 2 All factual references derive from Wade-James’s First Amended Complaint, unless otherwise noted, 28 and well-pleaded factual allegations are accepted as true for purposes of this Motion. See Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009). 1 termination. (Id. ¶ 43.) Thereafter, on October 5, 2021, two of Sanofi’s managers and 2 its Human Resources Representatives met with Wade-James to provide notice of her 3 employment termination, which was made effective that day due to failure to comply 4 with Sanofi’s vaccine mandate. (Id. ¶ 44.) In her exit materials, Wade-James indicated 5 that Sanofi’s denial of her religious accommodation request was discriminatory. (Id. 6 ¶ 47.) 7 Wade-James subsequently initiated this action against Sanofi for religious 8 discrimination in violation of California Government and Labor Codes.3 (Decl. John 9 Ayers-Mann ISO Removal Ex. A (“Compl.”) ¶ 1, ECF No. 1-1.) Wade-James alleged 10 eight causes of action, including unlawful religious discrimination, failure to 11 accommodate, failure to prevent discrimination, retaliation, wrongful termination, and 12 failure to timely provide access to employee payroll records. (Id. ¶¶ 63–139.) Sanofi 13 moved to dismiss several causes of action. (Mot. Dismiss Compl., ECF No. 10.) The 14 Court granted Sanofi’s motion in part, dismissing the first through third causes of action 15 with leave to amend, and the sixth cause of action without leave to amend. (Order re 16 Mot. Dismiss Compl. (“Prior Order”) 14, ECF No. 20.) The Court denied the balance 17 of the motion. (Id.) 18 Wade-James timely amended her complaint and now alleges the following five 19 causes of action: (1) unlawful discrimination (Gov’t Code § 12490(a)4); (2) failure to 20 reasonably accommodate (Gov’t Code § 12490(l)); (3) failure to prevent discrimination 21 (Gov’t Code § 12940(k)); (4) failure to timely provide access to employee payroll 22 records (Lab. Code § 226); and (5) unfair business practices (Bus. & Prof. Code 23 § 17200). (Id. ¶¶ 66–114, 133–37.5) Sanofi moves to dismiss Wade-James’s first three 24 causes of action pursuant to Rule 12(b)(6) for failure to state a claim. (See generally 25 Mot.) The Motion is fully briefed. (Opp’n, ECF No. 26; Reply, ECF No. 27.) 26 27 3 Unless otherwise noted, all further references are to California codes. 28 4 These Government Code sections are part of the Fair Employment and Housing Act (“FEHA”). 5 The First Amended Complaint does not include paragraphs numbered 115 through 132. 1 III. LEGAL STANDARD 2 A court may dismiss a complaint under Rule 12(b)(6) for lack of a cognizable 3 legal theory or insufficient facts pleaded to support an otherwise cognizable legal 4 theory. Balistreri v. Pacifica Police Dep’t, 901 F.2d 696, 699 (9th Cir. 1988). To 5 survive a dismissal motion, a complaint need only satisfy the minimal notice pleading 6 requirements of Rule 8(a)(2)—a short and plain statement of the claim. Porter v. Jones, 7 319 F.3d 483, 494 (9th Cir. 2003). The factual “allegations must be enough to raise a 8 right to relief above the speculative level.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 9 555 (2007). That is, the complaint must “contain sufficient factual matter, accepted as 10 true, to state a claim to relief that is plausible on its face.” Iqbal, 556 U.S. at 678 11 (internal quotation marks omitted). 12 The determination of whether a complaint satisfies the plausibility standard is a 13 “context-specific task that requires the reviewing court to draw on its judicial 14 experience and common sense.” Id. at 679. A court is generally limited to the pleadings 15 and must construe all “factual allegations set forth in the complaint . . . as true and . . . 16 in the light most favorable” to the plaintiff. Lee v. City of Los Angeles, 250 F.3d 668, 17 679 (9th Cir. 2001). However, a court need not blindly accept conclusory allegations, 18 unwarranted deductions of fact, and unreasonable inferences. Sprewell v. Golden State 19 Warriors, 266 F.3d 979, 988 (9th Cir. 2001).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Zeinali v. Raytheon Co.
636 F.3d 544 (Ninth Circuit, 2011)
Carrico v. City and County of San Francisco
656 F.3d 1002 (Ninth Circuit, 2011)
Robert Rodriguez v. Airborne Express
265 F.3d 890 (Ninth Circuit, 2001)
Kathryn Sheppard v. David Evans and Assoc.
694 F.3d 1045 (Ninth Circuit, 2012)
Manzarek v. St. Paul Fire & Marine Insurance
519 F.3d 1025 (Ninth Circuit, 2008)
United States v. Morris
738 F. Supp. 20 (District of Columbia, 1990)
Dickson v. Burke Williams, Inc.
234 Cal. App. 4th 1307 (California Court of Appeal, 2015)
Lee v. City of Los Angeles
250 F.3d 668 (Ninth Circuit, 2001)
Sprewell v. Golden State Warriors
266 F.3d 979 (Ninth Circuit, 2001)
Porter v. Jones
319 F.3d 483 (Ninth Circuit, 2003)
Achal v. Gate Gourmet, Inc.
114 F. Supp. 3d 781 (N.D. California, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
Stacey Wade-James v. Genzyme Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/stacey-wade-james-v-genzyme-corporation-cacd-2025.